Ibaraki, Japan

Masahiko Marumoto

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Tsumura Co., Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiko Marumoto. Retrieved from https://idiyas.com/inventor/masahiko-marumoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiko Marumoto: Innovator in Calcitonin Derivatives

Introduction

Masahiko Marumoto is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on calcitonin derivatives. His innovative approach has led to the development of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Masahiko Marumoto holds a patent for calcitonin derivatives. This patent represents a crucial advancement in the treatment of various medical conditions, highlighting his role as a key innovator in this area. He has 1 patent to his name, reflecting his commitment to research and development.

Career Highlights

Throughout his career, Marumoto has worked with esteemed organizations, including Tsumura Co., Ltd. His experience in these companies has allowed him to refine his skills and contribute to significant advancements in the pharmaceutical industry. His work has been instrumental in the development of new therapeutic options.

Collaborations

Masahiko Marumoto has collaborated with notable individuals such as Ronald C. Orlowski and Satoshi Hanamura. These partnerships have enriched his research and expanded the impact of his innovations in the field.

Conclusion

Masahiko Marumoto's contributions to the field of calcitonin derivatives exemplify his dedication to innovation and medical advancement. His work continues to influence the pharmaceutical landscape, making him a significant figure in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…